Close

Oppenheimer Q2 Review on Cadence Pharma (CADX): Supply Shortage Not Expected From Recall

Go back to Oppenheimer Q2 Review on Cadence Pharma (CADX): Supply Shortage Not Expected From Recall
Cadence Pharmaceuticals, Inc. (NASDAQ: CADX) Delayed: 13.98 --0 (-0%)
Previous Close $13.98    52 Week High $11.92 
Open $13.98    52 Week Low $4.45 
Day High $13.98    P/E N/A 
Day Low $13.98    EPS $-0.49 
Volume 282,940